CAPITAL B (ALCPB.PA) Fundamental Analysis & Valuation

EPA:ALCPB • FR0011053636

Current stock price

0.633 EUR
-0.03 (-3.95%)
Last:

This ALCPB.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ALCPB.PA Profitability Analysis

1.1 Basic Checks

  • ALCPB had negative earnings in the past year.
  • In the past year ALCPB has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ALCPB reported negative net income in multiple years.
  • Of the past 5 years ALCPB 4 years had a positive operating cash flow.
ALCPB.PA Yearly Net Income VS EBIT VS OCF VS FCFALCPB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

  • ALCPB's Return On Assets of -0.95% is in line compared to the rest of the industry. ALCPB outperforms 44.64% of its industry peers.
  • Looking at the Return On Equity, with a value of -3.59%, ALCPB is in line with its industry, outperforming 43.75% of the companies in the same industry.
Industry RankSector Rank
ROA -0.95%
ROE -3.59%
ROIC N/A
ROA(3y)-22.98%
ROA(5y)-12.96%
ROE(3y)-97.65%
ROE(5y)-38.94%
ROIC(3y)N/A
ROIC(5y)N/A
ALCPB.PA Yearly ROA, ROE, ROICALCPB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

1.3 Margins

  • ALCPB's Profit Margin has been stable in the last couple of years.
  • ALCPB has a worse Gross Margin (51.66%) than 65.18% of its industry peers.
  • ALCPB's Gross Margin has improved in the last couple of years.
  • ALCPB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y0.95%
GM growth 3Y3.05%
GM growth 5Y5.75%
ALCPB.PA Yearly Profit, Operating, Gross MarginsALCPB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. ALCPB.PA Health Analysis

2.1 Basic Checks

  • ALCPB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALCPB has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ALCPB has more shares outstanding
  • The debt/assets ratio for ALCPB has been reduced compared to a year ago.
ALCPB.PA Yearly Shares OutstandingALCPB.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ALCPB.PA Yearly Total Debt VS Total AssetsALCPB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • Based on the Altman-Z score of 1.55, we must say that ALCPB is in the distress zone and has some risk of bankruptcy.
  • ALCPB has a Altman-Z score of 1.55. This is comparable to the rest of the industry: ALCPB outperforms 45.54% of its industry peers.
  • A Debt/Equity ratio of 2.39 is on the high side and indicates that ALCPB has dependencies on debt financing.
  • ALCPB's Debt to Equity ratio of 2.39 is on the low side compared to the rest of the industry. ALCPB is outperformed by 86.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.39
Debt/FCF N/A
Altman-Z 1.55
ROIC/WACCN/A
WACC8.07%
ALCPB.PA Yearly LT Debt VS Equity VS FCFALCPB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

  • ALCPB has a Current Ratio of 53.77. This indicates that ALCPB is financially healthy and has no problem in meeting its short term obligations.
  • ALCPB has a better Current ratio (53.77) than 99.11% of its industry peers.
  • A Quick Ratio of 53.77 indicates that ALCPB has no problem at all paying its short term obligations.
  • ALCPB has a better Quick ratio (53.77) than 99.11% of its industry peers.
Industry RankSector Rank
Current Ratio 53.77
Quick Ratio 53.77
ALCPB.PA Yearly Current Assets VS Current LiabilitesALCPB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ALCPB.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 92.34% over the past year.
  • ALCPB shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.76% yearly.
  • The Revenue for ALCPB has decreased by -28.85% in the past year. This is quite bad
  • The Revenue has been growing by 43.44% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)92.34%
EPS 3YN/A
EPS 5Y10.76%
EPS Q2Q%-180.23%
Revenue 1Y (TTM)-28.85%
Revenue growth 3Y-4.3%
Revenue growth 5Y43.44%
Sales Q2Q%-23.1%

3.2 Future

  • The Earnings Per Share is expected to grow by 25.99% on average over the next years. This is a very strong growth
  • ALCPB is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -22.16% yearly.
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next Year-64%
Revenue Next 2Y-35.51%
Revenue Next 3Y-22.16%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALCPB.PA Yearly Revenue VS EstimatesALCPB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
ALCPB.PA Yearly EPS VS EstimatesALCPB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 -0.02 -0.04 -0.06 -0.08 -0.1

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALCPB.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALCPB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALCPB.PA Price Earnings VS Forward Price EarningsALCPB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCPB.PA Per share dataALCPB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15

4.3 Compensation for Growth

  • ALCPB's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y25.99%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALCPB.PA Dividend Analysis

5.1 Amount

  • No dividends for ALCPB!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALCPB.PA Fundamentals: All Metrics, Ratios and Statistics

CAPITAL B

EPA:ALCPB (4/28/2026, 7:00:00 PM)

0.633

-0.03 (-3.95%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Industry Strength10.81
Industry Growth60.67
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners2.41%
Inst Owner ChangeN/A
Ins Owners7.41%
Ins Owner ChangeN/A
Market Cap172.31M
Revenue(TTM)12.17M
Net Income(TTM)-1.88M
Analysts84.44
Price Target1.73 (173.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 14.16
P/FCF N/A
P/OCF N/A
P/B 3.29
P/tB 5.4
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.04
BVpS0.19
TBVpS0.12
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -0.95%
ROE -3.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.66%
FCFM N/A
ROA(3y)-22.98%
ROA(5y)-12.96%
ROE(3y)-97.65%
ROE(5y)-38.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y0.95%
GM growth 3Y3.05%
GM growth 5Y5.75%
F-Score2
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 2.39
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 121.81%
Cap/Sales 17.86%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 53.77
Quick Ratio 53.77
Altman-Z 1.55
F-Score2
WACC8.07%
ROIC/WACCN/A
Cap/Depr(3y)108.27%
Cap/Depr(5y)N/A
Cap/Sales(3y)15.29%
Cap/Sales(5y)15.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.34%
EPS 3YN/A
EPS 5Y10.76%
EPS Q2Q%-180.23%
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-28.85%
Revenue growth 3Y-4.3%
Revenue growth 5Y43.44%
Sales Q2Q%-23.1%
Revenue Next Year-64%
Revenue Next 2Y-35.51%
Revenue Next 3Y-22.16%
Revenue Next 5YN/A
EBIT growth 1Y67.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-2136.47%
EBIT Next 3Y-117.27%
EBIT Next 5YN/A
FCF growth 1Y-303.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-192.19%
OCF growth 3Y-56.48%
OCF growth 5Y34.81%

CAPITAL B / ALCPB.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CAPITAL B (ALCPB.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALCPB.PA.


What is the valuation status of CAPITAL B (ALCPB.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to CAPITAL B (ALCPB.PA). This can be considered as Overvalued.


What is the profitability of ALCPB stock?

CAPITAL B (ALCPB.PA) has a profitability rating of 2 / 10.


How financially healthy is CAPITAL B?

The financial health rating of CAPITAL B (ALCPB.PA) is 4 / 10.